Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
															Search

		Submit


Tuberculosis (TB)


Facebook
        Twitter
        LinkedIn
        Syndicate





TB-Related Articles										Related Pages
										**Journal Articles Published by Division of TB Elimination (DTBE) Authors**
**2013 DTBE journal articles**
Abraham BK, Winston CA, Magee E, Miramontes R. Tuberculosis among Africans living in the United States, 2000–2009. Journal of Immigrant and Minority Health 2013 April; 15 (2): 381-389.
Auld SC, Kim L, Webb EK, Podewils LJ, Uys M. Completeness and concordance of TB and HIV surveillance systems for TB-HIV co-infected patients in South Africa. Int J Tuberc Lung Dis 2013 Feb 1; 17(2):186-91.Year202120202019201820172016201520142013Auld SC, Pevzner E. Reaching beyond our Xpert potential: reflections on the 43rd Union World Conference. [Correspondence.] Int J Tuberc Lung Dis 2013 March 1: 17(3):423–424.
Cegielski JP, Griffith DE, McGaha PK, Wolfgang M, Robinson CB, Clark PA, Hassell WL, Robison VA, Walker KP Jr., and Wallace C. Eliminating tuberculosis one neighborhood at a time. Am J Public Health 2013; 103: 1292–1300. doi:10.2105/AJPH.2012.300781.
Chai SJ, Mattingly DC, Varma JK. Protecting health care workers from tuberculosis in China: a review of policy and practice in China and the United States.external icon Health Policy Plan. 2013 Jan; 28(1): 100-9. DOI: 10.1093/heapol/czs029. Epub 2012 Mar 16.
Clark IT, Lobato MN, Gutierrez J, Sosa LE. HIV status among patients with tuberculosis and HIV testing practices by Connecticut health care providers. Journal of the International Association of Providers of AIDS Care 2013 March 4. Epub ahead of print. DOI: 10.1177/2325957412473649.
Click ES, Winston CA, Oeltmann JE, Moonan PK, Mac Kenzie WR. Association between *Mycobacterium tuberculosis* lineage and time to sputum culture conversion. The International Journal of Tuberculosis and Lung Disease 2013 July 1; 17(7): 878-884.
Colson PW, Hirsch-Moverman Y, Bethel J, Vempaty P, et al. Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada. Int J Tuberc Lung Dis 2013 Apr;17(4):473-9. DOI: 10.5588/ijtld.12.0697.
Donald PR, Ahmed A, Burman WJ, Cotton MF, Graham SM, Mendel C, McIlleron H, Mac Kenzie WR, Nachman S, Schaaf HS, Starke JR, Wingfield C, Hesseling AC. Requirements for the clinical evaluation of new anti-tuberculosis agents in childrenexternal icon. IJTLD 2013 June 1; 17(6): 794-799.
Gacek P, Sosa L, Lobato MN. New overseas screening guidelines reduce imported tuberculosis to Connecticut. *Connecticut Medicine* 2013; 77:325–330.
Hales CM, Heilig CM, Chaisson R, Leung CC, Chang KC, Goldberg SV, Gordin F, Johnson JL, Muzanyi G, Saukkonen J, Vernon A, Villarino ME, Burman WJ. The association between symptoms and microbiologically defined response to tuberculosis treatment. Ann Am Thorac Soc 2013 Feb;10(1):18-25.
Hirsch-Moverman Y, Wall K, Maiuri AM, Khan AR, Weinfurter P, Munk E, DeLuca N. Acceptability of Interferon-gamma release assays among healthcare workers who receive routine employee tuberculosis testing. International Journal of Occupational and Environmental Health 2013.
Kato-Maeda M, Ho C, Passarelli B, Banaei N, Grinsdale J, Flores L, Anderson J, Murray M, Rose G, Kawamura LM, Pourmand N, Tariq MA, Gagneux S, Hopewell PC. Use of whole genome sequencing to determine the microevolution of Mycobacterium tuberculosis during an outbreak. PLoS One 2013. DOI: 10.1371/journal.pone.0058235. Epub 2013 Mar 5.
Kim L, Moonan PK, Yelk Woodruff RS, Kammerer JS, Haddad MB. Epidemiology of recurrent tuberculosis in the United States, 1993-2010. [Short communication.] Int J Tuberc Lung Dis 2013 Mar; 17(3): 357-60; DOI: 10.5588/ijtld.12.0640.
Kong DG, Watt JP, Marks S, Flood J. HIV status determination among tuberculosis patients from California during 2008. J Public Health Manag Pract 2013 Mar;19(2):169-77.
Kurbatova E, Kaminski D, Cegieldki P. Performance of Cepheid® Xpert MTB/RIF® and TB-Biochip® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis. Eur J Clin Microbiol Infect Dis 2013 June 1.
Lindquist S, Allen S, Field K, Ghosh S, Haddad MB, Narita M, and Oren E. Prioritizing tuberculosis clusters by genotype for public health action, Washington, USA. [Dispatch.] Emerg Infect Dis 2013 March; 19 (3): 493-495. Available online at http://wwwnc.cdc.gov/eid/article/19/3/12-1453_article.htm
Lo TQ, Oeltmann JE, Odhiambo FO, Beynon C, Pevzner E, Cain KP, Laserson KF, Phillips-Howard PA. Alcohol use, drunkenness and tobacco smoking in rural western Kenya. Trop Med Int Health 2013 Apr;18(4):506-15.
Magee MJ, Bloss E, Shin SS, Contreras C, Arbanil Huamane H, Calderon Ticona J, Bayona J, Bonilla C, Yagui M, Jave O, Cegielski JP. Clinical characteristics, drug resistance, and treatment outcomes among tuberculosis patients with diabetes in Peru. 2013 Int J Infect Dis. 2013 Jun;17(6):e404-12; http://dx.doi.org/10.1016/j.ijid.2012.12.029external icon.
Mancuso JD, Bernardo J, Mazurek GH. The elusive “gold” standard for detecting Mycobacterium tuberculosis infection. AJRCCM 2013 Jan. 15; 187 (2): 122-124; DOI: 10.1164/rccm.201211-2033ED.
Marks SM, Cronin W, Venkatappa T, Maltas G, Chon S, Sharnprapai S, Gaeddert M, Tapia J, Dorman SE, Etkind S, Crosby C, Blumberg HM, and Bernardo J. The health-system benefits and cost-effectiveness of using M*ycobacterium tuberculosis* Direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States. Clin Infect Dis 2013 May 22; doi:10.1093/cid/cit336.
Marrone MT, Venkataramanan V, Goodman M, Hill AC, Jereb JR, Mase SR. Surgical interventions for drug-resistant tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis 2013; 17 (1): 1-12.
Moonan PK, Teeter LD, Salcedo K, Ghosh S, Ahuja SD, Flood J, Graviss EA. Transmission of multidrug-resistant tuberculosis in the USA: a cross-sectional study.external icon Lancet Infect Dis. 2013 Jun 4. doi:pii: S1473-3099(13)70128-2. 10.1016/S1473-3099(13)70128-2. [Epub ahead of print]
Pasipanodya JG, Moonan PK, Vecino E, Miller T, Fernandez M, Slocum P, Drewyer G, Weis SE. Allopatric tuberculosis host-pathogen relationships are associated with greater pulmonary impairment. Infect Genet Evol. 2013; S1567-1348(13):64-6.external icon (Mar 15)
Reeves AZ, Campbell PJ, Sultana R, Malik S, Murray M, Plikaytis BB, Shinnick TM, Posey JE. Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5′ untranslated region of whiB7. Antimicrob Agents Chemother 2013 Apr; 57(4): 1857-65. DOI: 10.1128/AAC.02191-12.
Sable SB. Programmed Death 1 Lives Up to Its Reputation in Active Tuberculosis.external icon J Infect Dis. 2013 Jun 5.
Sibanda T, Tedla Z, Nyirenda S, Agizew T, Marape M, Miranda AG, Reuter H, Johnson JL, Samandari T. Anti-tuberculosis treatment outcomes in HIV-infected adults exposed to isoniazid preventive therapy in Botswana. Int J Tuberc Lung Dis. 2013 Feb 1;17(2):178-85. DOI: 10.5588/ijtld.12.0314.
Swindells S, Komarow L, Tripathy S, Cain KP, Macgregor RR, Achkar JM, Gupta A, Veloso VG, Asmelash A, Omoz-Oarhe AE, Gengiah S, Lalloo U, Allen R, Shiboski C, Andersen J, Qasba SS, Katzenstein DK; DS Clinical Trials Group 5253 Study Team. Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253. Int J Tuberc Lung Dis 2013 Apr;17(4):532-9. DOI: 10.5588/ijtld.12.0737.
Taylor AW, Mosimaneotsile B, Mathebula U, Mathoma A, Moathlodi R, Theebetsile I, Samandari T. Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy. Infect Dis Obstet Gynecol 2013: 195637; http://dx.doi.org/10.1155/2013/195637.
Vernon A. Treatment of latent tuberculosis infection. Semin Respir Crit Care Med 2013 Feb;34(1):67-86.
Vinnard C, Wileyto EP, Bisson GP, and Winston CA. First use of multiple imputation with the National Tuberculosis Surveillance System. Epidemiology Research International 2013 Jan. DOI:10.1155/2013/875234.
Vishnu PH, Bhat P, Bansal A, Satyanarayana S, Alavadi U, Ohri BS, Rao MS, Desikan P, Jaju J, Rao VG, Moonan PK. Is bleach-sedimented smear microscopy an alternative to direct microscopy under programme conditions in India? Public Health Action. 2013; 3(1):23-25.external icon (March 21).
Yelk Woodruff RS, Winston CA, Miramontes R. Predicting U.S. tuberculosis case counts through 2020. PLoS ONE 8(6) June 13, 2013; e65276. doi:10.1371/journal.pone.0065276.
							
					
						Page last reviewed:  June 21, 2013					Content source: 	Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention homeTuberculosis
Basic TB Factsplus icon
How TB Spreads
Latent TB Infection and TB Disease
Signs & Symptoms
TB Risk Factors
Exposure to TB
TB Prevention
Vaccines
TB & HIV Coinfection
TB and Diabetes
TB Terms
Personal Storiesplus icon
Stories by Topic
Archived Stories
Testing & Diagnosisplus icon
Who Should be Tested
Testing for TB Infection
Testing in BCG-Vaccinated Persons
TB Screening and Testing of Health Care Personnel
Testing During Pregnancy
Diagnosing latent TB infection and TB disease
Treatmentplus icon
Deciding When to Treat Latent TB Infection
Treatment Regimens for Latent TB Infection (LTBI)
Treatment for TB Disease
Adverse Events
TB Treatment of Persons Living with HIV
TB Treatment and Pregnancy
TB Treatment for Children
Drug-Resistant TB
Researchplus icon
TB Epidemiologic Studies Consortiumplus icon
Research Projects
Publications
TB Trials Consortiumplus icon
Study Descriptions
Background
Behavioral & Social Science Research
Health Care Settingsplus icon
TB Infection Control in Health Care Settings
Resources for TB Screening and Testing of Health Care Personnelplus icon
Frequently Asked Questions
TB in Specific Populationsplus icon
Health Disparities
Asian Persons
Black or African American Persons
Hispanic or Latino Persons
Children
Pregnancy
Correctional Facilities
People Experiencing Homelessness
International Travelers
Laboratory Informationplus icon
Drug Susceptibility Testing
False-Positive Investigation Toolkit
Interim Laboratory Biosafety Guidance for XDR *Mycobacterium* tuberculosis strains
Model Performance Evaluation Program (MPEP)
Rapid Molecular Testing to Detect Drug-Resistant TB in the USplus icon
Executive Summary
Introduction
Background on Tests for Molecular Detection of DR
General Considerations and Principles for a Molecular DR Testing Service
Possible Scenarios and Scope of Testing for a Molecular DR Testing Service
Research Needs
General Recommendations of the Expert Panel
Communication Plan for the Report
Recommendations
References
Panel Members and CDC Participants
Appendix 1
Appendix 2
Appendix 3
The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TBplus icon
General Considerations
General Recommendations of the Expert Panel
Recommendations to ACET, CDC, DTBE
Data & Statisticsplus icon
TB Incidence in the United States
Reported TB in the US, 2019 Surveillance Report
Trends in Tuberculosis 2019
Tuberculosis in the United States, 2019 (Slide Set)
Archived Surveillance Reports and Slide Sets
2019 State and City Report
Archived State and City Reports
Professional Resources & Toolsplus icon
Tools for Healthcare Providersplus icon
Interactive Core Curriculum on Tuberculosis: What the Clinician Should Know
Resources for TB Programsplus icon
Notice of Funding Opportunity (NOFO)
Program Evaluation
TB Centers of Excellence
TB Community Engagement Network
Publications & Productsplus icon
Patient and Public Materials
Fact Sheetsplus icon
General
Data & Statistics
Drug-Resistant TB
Infection Control & Prevention
TB in Specific Populations
Treatment
Testing & Diagnosis
Vaccines & Immunizations
Guidelinesplus icon
Control & Elimination
Drug-Resistant TB
Infection Control & Prevention
Laboratory & Genotyping
TB & HIV
TB in Specific Populations
Testing & Diagnosis
Treatment
Vaccines & Immunizations
Archived TB Guidelines
Guides & Toolkitsplus icon
Aggregate Reports
CDC TB Surveillance Training
Core Curriculum
Effective TB Interviewing for Contact Investigation
Ethnographic Guides
False-Positive Investigation Toolkit
Forging Partnerships to Eliminate TB
Guide to Application of Genotyping
LTBI: A Guide for Primary Health Care Providers
Mantoux Tuberculin Skin Testing Products
Report of Verified Case of Tuberculosis (RVCT)
Self-Study Modules
TB Contact Investigation Interviewing Skills Course
TB eDOT Toolkit
Understanding the TB Cohort Review Process
Newslettersplus icon
TB Notes, No. 1, 2021
TB Notes, No. 4, 2020
TB Notes, No. 3, 2020
TB Notes, No. 2, 2020
TB Notes, No. 1, 2020
TB Notes, No. 4, 2019
TB Notes, No. 3, 2019
TB Notes, No. 2, 2019
TB Notes, No. 1, 2019
TB Notes, No. 6, 2018
TB Notes, No. 5, 2018
TB Notes, No. 4, 2018
TB Notes, No. 3, 2018
TB Notes, No. 2, 2018
TB Notes, No. 1, 2018
TB Notes, No. 5, 2017
TB Notes, No. 4, 2017
TB Notes, No. 3, 2017
TB Notes, No. 2, 2017
TB Notes, No. 1, 2017
TB Notes, No. 5, 2016
TB Notes, No. 4, 2016
TB Notes, No. 3, 2016
TB Notes, No. 2, 2016
TB Notes, No. 1, 2016
Pamphlets, Brochures, Bookletsplus icon
Questions and Answers
Patient Education Series
Tuberculosis – Get the Facts
Tuberculosis – The Connection between TB and HIV
12-Dose Regimen for Latent TB Infection-Patient Education Brochure
Postersplus icon
Mantoux Tuberculin Skin Test Wall Chart
World TB Day
Think TB
Stop TB
Take on TB
Reports & Articlesplus icon
DTBE Authored Journal Articles
Tuberculosis Laboratory Aggregate Reports
Slide Setsplus icon
Introduction to Tuberculosis
Epidemiology of Tuberculosis Among Non-U.S.​–Born Persons in the United States, 1993–2016
Self-Study Modules on Tuberculosis, 1-5 Slide Sets
The Tuberculosis (TB) in Correctional Settingsplus icon
Facilitator Guide
Introduction to TB Genotyping
Epidemiology of Tuberculosis in Correctional Facilities, United States, 1993-2017
Prevention and Control of Tuberculosis in Correctional and Detention Facilities
Guidelines for Preventing the Transmission of M. TB in Health care Settings
Investigation of Contacts of Persons with Infectious TB
Epidemiology of Pediatric Tuberculosis in the United States
Targeted Tuberculosis Testing and Treatment of Latent Tuberculosis Infection
Electronic Tools & Resources
Web-Based Courses & Webinarsplus icon
TB 101 for Health Care Workersplus icon
TB 101
Interactive Core Curriculum
Content Syndication
Infographicsplus icon
Social Media Graphics
Customizable Take on TB Infographic with Instructions
Events
World TB Dayplus icon
Resources
U.S. TB Championsplus icon
2021 CDC U.S. TB Elimination Champions
2020 CDC U.S. TB Elimination Champions
2019 CDC U.S. TB Elimination Champions
2018 CDC U.S. TB Elimination Champions
2017 CDC U.S. TB Elimination Champions
2016 CDC U.S. TB Elimination Champions
News & Events
History
Featuresplus icon
TB Risk Factors
Treating Latent TB Infection with Short-Course Regimens
World Tuberculosis (TB) Day 2021
World Tuberculosis (TB) Day 2020
Linksplus icon
State TB Control Offices
About Usplus icon
Mission Statement and Activitiesplus icon
DTBE Strategic Plan
National TB Program Objectives
Organization Chart
Advisory Groupsplus icon
Federal TB Task Force


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue